Guardant Health Amends Executive Compensation Arrangements
Ticker: GH · Form: 8-K · Filed: Feb 1, 2024 · CIK: 1576280
| Field | Detail |
|---|---|
| Company | Guardant Health, Inc. (GH) |
| Form Type | 8-K |
| Filed Date | Feb 1, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: compensatory-arrangements, executive-compensation, corporate-governance
TL;DR
**Guardant Health just tweaked executive pay, watch for impact on leadership and costs.**
AI Summary
Guardant Health, Inc. filed an 8-K on February 1, 2024, reporting an event on January 26, 2024, related to changes in its executive compensation arrangements. This filing indicates that the company is making adjustments to how it compensates its key officers, which could impact future financial performance and executive retention. For investors, understanding these changes is crucial as executive compensation can influence management's incentives and the company's overall cost structure, potentially affecting stock valuation.
Why It Matters
Changes in executive compensation can signal shifts in company strategy or financial health, directly impacting investor confidence and the company's ability to attract and retain top talent.
Risk Assessment
Risk Level: medium — While not inherently negative, changes in executive compensation can introduce uncertainty regarding leadership stability and future financial commitments, warranting investor attention.
Analyst Insight
A smart investor would monitor Guardant Health's upcoming filings for specific details on the executive compensation changes to assess their potential impact on the company's financial health and executive incentives.
Key Players & Entities
- Guardant Health, Inc. (company) — the registrant filing the 8-K
- January 26, 2024 (date) — date of the earliest event reported
- February 1, 2024 (date) — date the 8-K was filed
- Delaware (company) — state of incorporation for Guardant Health, Inc.
- 001-38683 (dollar_amount) — Commission File Number
Forward-Looking Statements
- Guardant Health will provide more specific details on the executive compensation changes in its next quarterly or annual report. (Guardant Health, Inc.) — high confidence, target: Q1 2024 Earnings Report
FAQ
What was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 26, 2024.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant as specified in its charter is GUARDANT HEALTH, INC.
What is Guardant Health, Inc.'s state of incorporation?
Guardant Health, Inc. is incorporated in Delaware.
What is the business address of Guardant Health, Inc.?
The business address of Guardant Health, Inc. is 3100 Hanover Street, Palo Alto, California 94304.
Under which item information category was this 8-K filed?
This 8-K was filed under 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers'.
Filing Stats: 460 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-02-01 16:20:32
Key Financial Figures
- $0.00001 — ange on which registered Common Stock, $0.00001 par value per share GH The Nasdaq G
Filing Documents
- d745810d8k.htm (8-K) — 20KB
- 0001193125-24-021871.txt ( ) — 135KB
- gh-20240126.xsd (EX-101.SCH) — 3KB
- gh-20240126_lab.xml (EX-101.LAB) — 17KB
- gh-20240126_pre.xml (EX-101.PRE) — 11KB
- d745810d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GUARDANT HEALTH, INC. Date: February 1, 2024 By: /s/ John G. Saia John G. Saia Chief Legal Officer and Corporate Secretary